We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATNX
8176
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
$165K ﹤0.01%
+530
New +$186K
GFN
8177
DELISTED
General Finance Corporation
GFN
$165K ﹤0.01%
+10,345
New +$145K
OTIC
8178
DELISTED
Otonomy, Inc.
OTIC
$164K ﹤0.01%
59,578
-3,577
-6% -$11.5K
CVRS
8179
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$164K ﹤0.01%
115,728
+77,829
+205% +$85.2K
SOIL
8180
DELISTED
Global X Fertilizers/Potash ETF
SOIL
$164K ﹤0.01%
+15,142
New +$160K
CLSD
8181
DELISTED
Clearside Biomedical
CLSD
$163K ﹤0.01%
1,764
-3,128
-64% -$372K
AFMD
8182
PUT
DELISTED
Affimed
AFMD
$162K ﹤0.01%
+3,720
New +$105K
TA
8183
DELISTED
TravelCenters of America LLC
TA
$162K ﹤0.01%
5,676
-394
-6% -$9K
RWGE.U
8184
DELISTED
Regalwood Global Energy Ltd. Units, each consisting of one Class A ordinary share and one-third of o
RWGE.U
$162K ﹤0.01%
15,718
+185
+1% +$1.9K
HMY icon
8185
PUT
Harmony Gold Mining
HMY
$12.1B
$161K ﹤0.01%
96,700
-11,600
-11% -$19.5K
SRGA
8186
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$160K ﹤0.01%
1,186
+492
+71% +$67.8K
BAS
8187
PUT
DELISTED
Basis Energy Services, Inc.
BAS
$160K ﹤0.01%
16,000
+1,200
+8% +$11.6K
ASRT
8188
PUT
DELISTED
Assertio
ASRT
$159K ﹤0.01%
452
+19
+4% +$8.3K
KALA icon
8189
CALL
KALA BIO
KALA
$18.3M
$159K ﹤0.01%
+6
New +$183K
ORC
8190
PUT
Orchid Island Capital
ORC
$1.33B
$159K ﹤0.01%
+4,380
New +$172K
SNDX icon
8191
PUT
Syndax Pharmaceuticals
SNDX
$1.77B
$159K ﹤0.01%
19,700
+2,800
+17% +$20K
TGA
8192
DELISTED
Transglobe Energy Corp
TGA
$159K ﹤0.01%
47,509
+11,319
+31% +$37.9K
HMTV
8193
DELISTED
Hemisphere Media Group, Inc.
HMTV
$159K ﹤0.01%
11,379
-10,006
-47% -$131K
MFAC.U
8194
DELISTED
Megalith Financial Acquisition Corp. Units, each consisting of one share of Class A Common Stock, an
MFAC.U
$159K ﹤0.01%
+15,789
New +$159K
SLAI
8195
CALL
DELISTED
SOLAI Ltd ADS
SLAI
$158K ﹤0.01%
204
-75
-27% -$69K
SIOX
8196
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$158K ﹤0.01%
8,163
-3,412
-29% -$62.1K
HPR
8197
PUT
DELISTED
HighPoint Resources Corporation
HPR
$158K ﹤0.01%
+648
New +$185K
ENY
8198
DELISTED
Invesco Canadian Energy Income ETF
ENY
$158K ﹤0.01%
19,985
-34,309
-63% -$276K
ALTO icon
8199
Alto Ingredients
ALTO
$324M
$157K ﹤0.01%
82,390
+9,956
+14% +$22.3K
CYTK icon
8200
CALL
Cytokinetics
CYTK
$10.3B
$157K ﹤0.01%
15,900
+5,000
+46% +$40.1K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.